Biophytis

YTD

ALL

Why Robinhood?

You can watch Biophytis and buy or sell other stocks, ETFs, and their options commission-free!

About BPTS

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19.

CEO

Stanislas Veillet, PhD

CEOStanislas Veillet, PhD

Employees

Employees20

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

2006

Founded2006

Employees

Employees20

BPTS Key Statistics

Market cap

19.24M

Market cap19.24M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

19.89

Average volume19.89

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.60

52 Week high$3.60

52 Week low

$0.001

52 Week low$0.001

Biophytis

Why Robinhood?

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Show more

BPTS Key Statistics

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19.